ViCentra announced today that it made its Kaleido automated insulin pump immediately available, with no waiting period to get ...

CEO Robert B. Ford remains optimistic about the company's opportunity in the continuous glucose monitor (CGM) market.

For those familiar with diabetes technology, the Omnipod platform from Insulet (Nasdaq:PODD) is one most will know about.

Medtrum has shared findings supporting its technology for handling mealtime insulin delivery through its automated system.

[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) announced today that it received FDA 510(k) clearance for its next-generation insulin patch pump. Pivot, a tubeless patch pump, ...

PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump ...

Aptar Digital Health and Enable Injections announced a strategic partnership to deliver digital offerings with the enFuse ...

Insulet announced on social media today that it appointed a new SVP, chief quality, regulatory and compliance officer.

The Germantown, Maryland-based company launched Eversense 365, its implantable CGM in 2024. Eversense 365 rests under the ...

ViCentra told customers that it expects no immediate impact from Dexcom's planned discontinuation of the G6 CGM line.